Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Therapy
Findings advance knowledge in diabetes therapy research
March 6th, 2006
Reports from Tunisia, the United States and Poland highlight recent research on diabetes therapy. Study 1: One year course of oral sulodexide delays the progression of diabetic nephropathy. "Diabetic nephropathy is a multifactorial diabetic complication whose long-term consequences involve chronic renal insufficiency and increased rate of cardiovascular death. Besides oxidative stress, and hemodynamic changes, glycosaminoglycans (GAGs) are an additional component implicated in the onset of glomerular abnormalities. GAG replacement therapy was envisaged in the nineties for the treatment of diabetic nephropathy and sulodexide is the most extensively...
Source: Obesity & Diabetes Week (2006-03-06)
|
